Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-07-27

Clinical Trial Update: Comparison in the Treatment of Acute Cystitis Using Cephalosporin and Norfloxacin (CECI) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing cephalosporin versus norfloxacin for acute cystitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cephalosporin (cephalosporin)
  • Norfloxacin (Norfloxacin)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Cystitis | Phase 3 | Status: WITHDRAWN